22nd Century Group Inc (NYSEAMERICAN:XXII) saw strong trading volume on Monday . 2,312,500 shares traded hands during mid-day trading, a decline of 5% from the previous session’s volume of 2,436,533 shares.The stock last traded at $2.94 and had previously closed at $2.84.
Separately, Zacks Investment Research cut shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Thursday, August 16th.
22nd Century Group (NYSEAMERICAN:XXII) last posted its earnings results on Wednesday, November 7th. The biotechnology company reported $0.04 EPS for the quarter. The company had revenue of $6.26 million during the quarter.
Several institutional investors have recently modified their holdings of XXII. BlackRock Inc. increased its stake in 22nd Century Group by 46.6% during the 1st quarter. BlackRock Inc. now owns 2,809,955 shares of the biotechnology company’s stock valued at $6,602,000 after purchasing an additional 893,319 shares in the last quarter. NJ State Employees Deferred Compensation Plan bought a new stake in 22nd Century Group during the 2nd quarter valued at about $418,000. Cobblestone Capital Advisors LLC NY bought a new stake in 22nd Century Group during the 2nd quarter valued at about $159,000. Rhumbline Advisers bought a new stake in 22nd Century Group during the 2nd quarter valued at about $246,000. Finally, State Board of Administration of Florida Retirement System bought a new stake in 22nd Century Group during the 2nd quarter valued at about $167,000.
COPYRIGHT VIOLATION NOTICE: This news story was posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://transcriptdaily.com/2018/11/27/22nd-century-group-xxii-sees-large-volume-increase.html.
22nd Century Group Company Profile (NYSEAMERICAN:XXII)
22nd Century Group, Inc, a plant biotechnology company, provides technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and cannabinoids in hemp/cannabis plants through genetic engineering and plant breeding. It offers premium cigarettes under the RED SUN and MAGIC brands; and SPECTRUM, a line of research cigarettes for use in independent clinical studies.
Recommended Story: What is a Derivative?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.